Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001752864-20-000001
Filing Date
2020-01-15
Accepted
2020-01-15 16:39:26
Documents
1
Period of Report
2020-01-13

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 6171
  Complete submission text file 0001752864-20-000001.txt   8265
Mailing Address 400 CROSSING BOULEVARD BRIDGEWATER NJ 08807
Business Address 400 CROSSING BOULEVARD BRIDGEWATER NJ 08807 9088091300
Osmotica Pharmaceuticals plc (Issuer) CIK: 0001739426 (see all company filings)

EIN.: 000000000
SIC: 2834 Pharmaceutical Preparations

Mailing Address KARAISKAKI 6 CITY HOUSE LIMASSOL G4 3032
Business Address KARAISKAKI 6 CITY HOUSE LIMASSOL G4 3032 35725555000
Altchem Ltd (Reporting) CIK: 0001752864 (see all company filings)

State of Incorp.: G4 | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-38709 | Film No.: 20528641

Mailing Address 895 SAWYER ROAD MARIETTA GA 30062
Business Address 895 SAWYER ROAD MARIETTA GA 30062 7705094500
Orbit Co-Invest A-1 LLC (Reporting) CIK: 0001753129 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1218
Type: 4 | Act: 34 | File No.: 001-38709 | Film No.: 20528642